Skip to main content

Table 2 Participants’ characteristics and preferences. Specialized population

From: How to present economic evaluations to non-technical audiences? Randomized trials with professionals and the general population

 

Policy brief

(N = 46)

Executive summary (N = 54)

p-value

Women (N [%])

27 (58.70)

30 (55.56)

0.910

Age (mean [SD])

49.22 (10.38)

49.81 (13.27)

0.801

Profile (N [%])*

   

   Clinician

28 (60.87)

24 (44.44)

0.151

   Non-clinical manager

5 (10.87)

12 (22.22)

0.216

   Clinical manager

8 (17.39)

5 (9.26)

0.365

   Methodologist in HTA

7 (15.22)

16 (29.63)

0.142

Is the economic data of health technologies easy to understand? (N [%])

  

0.229

   No or little understandable

16 (34.78)

15 (27.78)

 

   More or less understandable

23 (50.00)

25 (46.30)

 

   Enough or completely understandable

7 (15.22)

14 (25.93)

 

In what formats do you prefer to receive results of research or HTA? (N [%])*

   

   Video

12 (26.09)

13 (24.07)

1

   Infographic

23 (50.00)

30 (55.56)

0.724

   Audio

3 (6.52)

6 (11.11)

0.654

   Text

27 (58.70)

32 (59.26)

1

   Scientific paper

35 (76.09)

40 (74.07)

1

  1. HTA: Health-technology assessment; SD: Standard deviation; * Multiple choice question